CANDICE HAMMERTON: Open Payments
NPI 1558306910 · LEWISTON, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,344 in 50 payments from 14 companies in 2025. Trend: 2023 $1,152 · 2024 $862 · 2025 $1,344
Food & beverage: $1,177Education: $167
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $382 |
| Sumitomo Pharma America, Inc. | 13 | $215 |
| UROGEN PHARMA, INC. | 5 | $182 |
| Olympus America Inc. | 5 | $106 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $78 |
| Ferring Pharmaceuticals Inc. | 4 | $74 |
| Merck Sharp & Dohme LLC | 2 | $63 |
| AstraZeneca Pharmaceuticals LP | 2 | $63 |
| Teleflex LLC | 1 | $54 |
| Myriad Genetic Laboratories, Inc. | 2 | $48 |
Products named: ERLEADA, GEMTESA, iTIND System, JELMYTO, Nubeqa, ADSTILADRIN, BRIDION, LYNPARZA.
Industry payments across ME — which companies pay providers there.
